Otto Bock HealthCare GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Otto Bock HealthCare GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7381
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product portfolio of the company includes prosthetics for limbs, joints, breasts, and extremities; wheelchairs, custom seating, walkers, and support and compression stockings; and back support bandages and shower seats. It offers an extensive range of patient care and professional services through its supply centers the world over. The company, along with its subsidiaries, operates in Europe, Asia-Pacific, Americas and Africa. Otto Bock is headquartered in Duderstadt, Germany.

Otto Bock HealthCare GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otto Bock HealthCare GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Otto Bock HealthCare GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Otto Bock HealthCare GmbH, Medical Equipment, Deal Details 10
Asset Purchase 10
Ottobock Acquires Bebionic Prosthetic Business from Steeper 10
Private Equity 11
EQT to Acquire 20% Stake in Otto Bock HealthCare 11
EQT and CVC Capital Partners Plan to Acquire 20% Stake in Otto Bock HealthCare 12
Health Evolution Acquires Majority Stake In Freedom Innovations, Prosthetic Device Company 13
Partnerships 14
Ekso Bionics Enters into Licensing Agreement with Otto Bock Healthcare 14
Otto Bock HealthCare Enters into Distribution Agreement with BionX Medical Technologies 15
Artec Enters into Distribution Agreement with Ottobock For 3D Scanners 16
Equity Offering 17
Otto Bock Healthcare Plans IPO 17
Acquisition 18
Otto Bock Acquires 51% Interest in Orthopraxis 18
Otto Bock Acquires 51% Interest in Chabloz Orthopedie 19
Parker Hannifin Acquires Minority Stake in Freedom Innovations 20
Otto Bock Healthcare Completes Acquisition Of Respecta 21
Otto Bock HealthCare Acquires Bio Cybernetics International 22
Otto Bock HealthCare GmbH – Key Competitors 23
Otto Bock HealthCare GmbH – Key Employees 24
Otto Bock HealthCare GmbH – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Corporate Communications 28
Jun 13, 2018: Ottobock Appoints Philipp Schulte-Noelle As CFO 28
May 03, 2018: Sarik Weber named Chief Digital Officer of Ottobock 29
Jan 25, 2018: Otto Bock HealthCare: Arne Jorn joins medtech manufacturer 30
Other Significant Developments 31
May 23, 2017: Integrum’s first delivery to Ottobock in the United States 31
May 10, 2017: Bioness and Ottobock Announce Strategic European Distribution Partnership 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Otto Bock HealthCare GmbH, Medical Equipment, Key Facts 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otto Bock HealthCare GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otto Bock HealthCare GmbH, Deals By Market, 2012 to YTD 2018 8
Otto Bock HealthCare GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ottobock Acquires Bebionic Prosthetic Business from Steeper 10
EQT to Acquire 20% Stake in Otto Bock HealthCare 11
EQT and CVC Capital Partners Plan to Acquire 20% Stake in Otto Bock HealthCare 12
Health Evolution Acquires Majority Stake In Freedom Innovations, Prosthetic Device Company 13
Ekso Bionics Enters into Licensing Agreement with Otto Bock Healthcare 14
Otto Bock HealthCare Enters into Distribution Agreement with BionX Medical Technologies 15
Artec Enters into Distribution Agreement with Ottobock For 3D Scanners 16
Otto Bock Healthcare Plans IPO 17
Otto Bock Acquires 51% Interest in Orthopraxis 18
Otto Bock Acquires 51% Interest in Chabloz Orthopedie 19
Parker Hannifin Acquires Minority Stake in Freedom Innovations 20
Otto Bock Healthcare Completes Acquisition Of Respecta 21
Otto Bock HealthCare Acquires Bio Cybernetics International 22
Otto Bock HealthCare GmbH, Key Competitors 23
Otto Bock HealthCare GmbH, Key Employees 24
Otto Bock HealthCare GmbH, Subsidiaries 25

List of Figures
Otto Bock HealthCare GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otto Bock HealthCare GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otto Bock HealthCare GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Otto Bock HealthCare GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Syniverse Holdings Inc:企業の戦略的SWOT分析
    Syniverse Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • Hunan Corun New Energy Co Ltd (600478)-エネルギー分野:企業M&A・提携分析
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries. It also manufactures ultra-intense bonding ni …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mr. Price Group Ltd.
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • New Gold Inc.:企業のM&A・事業提携・投資動向
    New Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China Biologic Products Inc (CBPO):企業の財務・戦略的SWOT分析
    China Biologic Products Inc (CBPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Holland Colours NV (HOLCO):企業の財務・戦略的SWOT分析
    Holland Colours NV (HOLCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • Calpine Corp:企業の戦略的SWOT分析
    Calpine Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SRI International:企業のM&A・事業提携・投資動向
    SRI International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SRI International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • ONGC Videsh Ltd-石油・ガス分野:企業M&A・提携分析
    Summary ONGC Videsh Ltd (OVL) is an upstream oil and gas company that explores for, develops and produces oil and gas from its assets. It focuses on acquisition of exploratory and production licenses in foreign countries. The company has working interests in several producing projects, exploration b …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆